The TGF-β1 Signaling Pathway as an Attractive Target in the Fibrosis Pathogenesis of Sj...
Mediators of Inflammation
Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and ...
Clinical & Experimental Immunology
Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-κB in Sjögren sy...
Neovascularization is prominent in the chronic inflammatory lesions of Sjögren's syndrome
International Journal of Experimental Pathology